ArticleCell death & disease2019

Author Correction: Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.

Xiang-Lin Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.